Background: Polypoidal choroidal vasculopathy (PCV) is an exudative maculopathy affecting vision, with clinical features distinct from neovascular age-related macular …
Purpose To determine the proportion of shallow irregular pigment epithelial detachments in eyes with pachychoroid features that harbor neovascular tissue and to study the morphology …
Y Imamura, M Engelbert, T Iida, KB Freund… - Survey of …, 2010 - Elsevier
More than a quarter century has passed since the original description of polypoidal choroidal vasculopathy (PCV) in 1982 as a peculiar hemorrhagic disorder involving the …
Verteporfin photodynamic therapy (vPDT) is a selective vaso-occlusive treatment that targets choroidal vascular abnormalities. It was initially developed to treat neovascular age-related …
M Cho, IA Barbazetto, KB Freund - American journal of ophthalmology, 2009 - Elsevier
purpose: To describe a neovascular pattern associated with treatment-refractory neovascular age-related macular degeneration (AMD). DESIGN: A retrospective …
I Maruko, T Iida, Y Sugano, M Saito, T Sekiryu - American journal of …, 2011 - Elsevier
PURPOSE: To evaluate the morphologic retinal and choroidal changes after verteporfin photodynamic therapy (PDT) with and without ranibizumab for polypoidal choroidal …
Previous clinical studies have suggested that pachychoroid can induce macular neovascularization (MNV) to develop pachychoroid neovasculopathy (PNV) and that PNV …
TYY Lai, WM Chan, DTL Liu, FOJ Luk… - British Journal of …, 2008 - bjo.bmj.com
Aim: To evaluate the efficacy of intravitreal bevacizumab (Avastin) with or without verteporfin photodynamic therapy (PDT) in the treatment of polypoidal choroidal vasculopathy (PCV) …
F Gomi, Y Tano - Current opinion in ophthalmology, 2008 - journals.lww.com
Although the polypoidal choroidal vasculopathy and age-related macular degeneration have been known to share common genetic factors, its clinical characteristics including the …